Premium
Mumbai-based privately held drugmaker Medley Pharmaceuticals Ltd has acquired the generic division of a UK-based firm Zanza Laboratories, a top company executive told VCCircle.The deal includes commercial and distribution infrastructure besides 39 marketing authorisations in the UK generic market in the cardiovascular, diabetes and gastrointestinal segments.The deal has been struck ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
